Search research articles
Contact Us
Filters
Showing results (1-10 of 418) with videos related to
Page
of 42
Sort By:
Frontiers in Cardiovascular Medicine
|
October 18, 2019
Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
David M Kaye, Shane Nanayakkara
Heart Failure Reviews
|
April 19, 2022
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Shane Nanayakkara, David M Kaye
Trends in Cardiovascular Medicine
|
May 23, 2006
Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects
Zhiyong Yang, David M Kaye
Human Mutation
|
December 11, 2008
Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension
Zhiyong Yang, David M Kaye
Clinical Therapeutics
|
September 20, 2015
Management of heart failure with preserved ejection fraction: a review
Shane Nanayakkara, David M Kaye
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 3, 2026
Finding the Limits of Hypothermic Oxygenated Perfusion
David McGiffin, David M Kaye
Nature Reviews. Drug Discovery
|
February 3, 2007
Drug discovery for heart failure: a new era or the end of the pipeline?
David M Kaye, Henry Krum
European Journal of Heart Failure
|
August 23, 2023
No longer from pillar to post: The first effective step in treating heart failure with preserved ejection fraction
Shane Nanayakkara, David M Kaye
Interventional Cardiology Clinics
|
May 31, 2020
Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney Injury
Shane Nanayakkara, David M Kaye
Circulation. Heart Failure
|
April 3, 2024
Making Waves in HFpEF: Unmasking Severe Left Atrial Myopathy During Exercise
Misha Dagan, David M Kaye
Page
of 42
Search research articles
Search
Showing results (1-10 of 418) with videos related to
Sort By:
Page
of 42
Frontiers in Cardiovascular Medicine
|
October 18, 2019
Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
David M Kaye, Shane Nanayakkara
Heart Failure Reviews
|
April 19, 2022
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
Shane Nanayakkara, David M Kaye
Trends in Cardiovascular Medicine
|
May 23, 2006
Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects
Zhiyong Yang, David M Kaye
Human Mutation
|
December 11, 2008
Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension
Zhiyong Yang, David M Kaye
Clinical Therapeutics
|
September 20, 2015
Management of heart failure with preserved ejection fraction: a review
Shane Nanayakkara, David M Kaye
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 3, 2026
Finding the Limits of Hypothermic Oxygenated Perfusion
David McGiffin, David M Kaye
Nature Reviews. Drug Discovery
|
February 3, 2007
Drug discovery for heart failure: a new era or the end of the pipeline?
David M Kaye, Henry Krum
European Journal of Heart Failure
|
August 23, 2023
No longer from pillar to post: The first effective step in treating heart failure with preserved ejection fraction
Shane Nanayakkara, David M Kaye
Interventional Cardiology Clinics
|
May 31, 2020
Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney Injury
Shane Nanayakkara, David M Kaye
Circulation. Heart Failure
|
April 3, 2024
Making Waves in HFpEF: Unmasking Severe Left Atrial Myopathy During Exercise
Misha Dagan, David M Kaye
Page
of 42